Pubdiz
Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z



Gene Symbol
Gene NameAliasesPrevious_Symbol

CYP2C9

cytochrome P450, family 2, subfamily C, polypeptide 9P450IIC9cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9


Gene CYP2C9 gene interaction
View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term
FrequencyCondition_Probility

Humans

5030.0

Animals

750.0

History, 20th Century

21.0

Research Support, Non-U.S. Gov't

2450.0

Forecasting

20.0

Antibodies/pharmacology

41.0

Antineoplastic Agents, Alkylating/*metabolism

342.0

*Aryl Hydrocarbon Hydroxylases

15017.0

Cytochrome P-450 Enzyme System/antagonists & inhibitors/*metabolism

2418.0

Enzyme Inhibitors/pharmacology

341.0

Isoenzymes/antagonists & inhibitors/metabolism

1622.0

Kinetics

810.0

Microsomes, Liver/drug effects/*enzymology

1023.0

Mixed Function Oxygenases/antagonists & inhibitors/*metabolism

510.0

Transfection

120.0

Aryl Hydrocarbon Hydroxylases/genetics/metabolism

316.0

Cytochrome P-450 Enzyme System/genetics/*metabolism

1711.0

*Drug Design

22.0

In Vitro

821.0

Mixed Function Oxygenases/genetics/metabolism

313.0

Pharmacogenetics

65.0

Pharmacology, Clinical

2100.0

Phenotype

220.0

Polymorphism, Genetic

290.0

Cytochrome P-450 Enzyme System/*metabolism

6613.0

Drug Interactions

554.0

Dose-Response Relationship, Drug

280.0

Half-Life

111.0

Lymphocytes/enzymology

33.0

Microsomes, Liver/*enzymology

3015.0

African Continental Ancestry Group/genetics

31.0

Aryl Hydrocarbon Hydroxylases/*genetics

2726.0

Asian Continental Ancestry Group/genetics

51.0

Comparative Study

930.0

Cytochrome P-450 CYP2E1/*genetics

21.0

European Continental Ancestry Group/genetics

30.0

*Gene Frequency

20.0

Genotype

900.0

Mixed Function Oxygenases/*genetics

139.0

Apoptosis/drug effects/*physiology

20.0

DNA/drug effects/*metabolism

240.0

DNA Fragmentation/drug effects

22.0

DNA Topoisomerases, Type I/*metabolism

27.0

Enzyme Inhibitors/*pharmacology

263.0

Reactive Oxygen Species/*metabolism

21.0

Staurosporine/*pharmacology

210.0

Tumor Cells, Cultured

170.0

Anti-Infective Agents/*pharmacology

26.0

Chromatography, High Pressure Liquid

502.0

Cytochrome P-450 Enzyme System/*antagonists & inhibitors/metabolism

1724.0

Female

1350.0

Male

1610.0

Microsomes, Liver/drug effects/enzymology

1414.0

Recombinant Proteins/antagonists & inhibitors

510.0

*Steroid 16-alpha-Hydroxylase

13774.0

Steroid Hydroxylases/*antagonists & inhibitors/metabolism

777.0

Blotting, Western

90.0

Cell Survival/drug effects

20.0

Cells, Cultured

290.0

Cytochrome P-450 Enzyme System/biosynthesis/*genetics

410.0

Gene Expression

60.0

Hepatocytes/*drug effects/enzymology

428.0

Protein Isoforms

30.0

RNA, Messenger/metabolism

60.0

Databases, Factual

20.0

Quantitative Structure-Activity Relationship

310.0

Cytochrome P-450 Enzyme System/chemistry/*metabolism

422.0

Isoenzymes/chemistry/metabolism

27.0

Models, Molecular

180.0

Base Sequence

130.0

Cytochrome P-450 Enzyme System/*genetics

419.0

DNA Primers

90.0

Oxidoreductases, N-Demethylating/*genetics

24.0

Steroid Hydroxylases/*genetics

2832.0

Adult

1170.0

Aryl Hydrocarbon Hydroxylases/genetics/*metabolism

520.0

Asian Continental Ancestry Group

41.0

Drug Therapy, Combination

20.0

Metabolic Clearance Rate

144.0

Mixed Function Oxygenases/genetics/*metabolism

714.0

*Polymorphism, Genetic

280.0

Taiwan

21.0

Acetylation

20.0

Carcinoma, Hepatocellular

41.0

Glucocorticoids/pharmacology

21.0

Hela Cells

20.0

Pharmacokinetics

719.0

Inhibitory Concentration 50

103.0

Microsomes, Liver/*drug effects

266.0

Alleles

430.0

*Genotype

31.0

Mutation

90.0

Risk Factors

70.0

Variation (Genetics)

80.0

Analysis of Variance

60.0

Area Under Curve

275.0

Biotransformation

315.0

Blood Glucose/*metabolism

31.0

Glyburide/blood/*pharmacokinetics

2100.0

Polymorphism, Genetic/*genetics

151.0

Flavonoids/*metabolism

233.0

Mice

70.0

Microsomes, Liver/enzymology

3013.0

Recombinant Proteins/metabolism

321.0

Species Specificity

120.0

Mass Fragmentography

52.0

Microsomes, Liver/*metabolism

2011.0

Mixed Function Oxygenases/*metabolism

128.0

*Monoterpenes

220.0

Oxidation-Reduction

322.0

Rats

300.0

Stereoisomerism

348.0

Steroid Hydroxylases/*metabolism

1031.0

Isoenzymes/metabolism

244.0

Research Support, U.S. Gov't, P.H.S.

1000.0

Cytochrome P-450 Enzyme System/*antagonists & inhibitors

1916.0

Isoenzymes/antagonists & inhibitors

512.0

Microsomes, Liver/drug effects/metabolism

36.0

Oxidoreductases, N-Demethylating/*antagonists & inhibitors

26.0

Cytochrome P-450 CYP2D6/*antagonists & inhibitors

333.0

Ethanolamines/metabolism

316.0

Histamine H1 Antagonists/*pharmacology

327.0

Hydroxylation

5315.0

Steroid Hydroxylases/*antagonists & inhibitors

457.0

Tolbutamide/metabolism

1066.0

African Continental Ancestry Group/*genetics

41.0

European Continental Ancestry Group/*genetics

92.0

Genetics, Population

20.0

Phenytoin/pharmacology

214.0

Warfarin/pharmacology

213.0

English Abstract

140.0

Genetic Predisposition to Disease

50.0

*Polymorphism, Single Nucleotide

40.0

Aryl Hydrocarbon Hydroxylases/*genetics/*metabolism

741.0

Cell Fractionation

20.0

Cell Line

160.0

China

30.0

Hypoglycemic Agents/metabolism

250.0

Liver/*enzymology

91.0

Recombinant Proteins/genetics/metabolism

91.0

Anti-Inflammatory Agents, Non-Steroidal/chemistry/metabolism

2100.0

Binding Sites/genetics

20.0

Structure-Activity Relationship

90.0

Substrate Specificity

442.0

European Continental Ancestry Group

60.0

Middle Aged

940.0

Prospective Studies

80.0

Regression Analysis

30.0

Cytochrome P-450 Enzyme System/antagonists & inhibitors

24.0

Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors/*metabolism

225.0

Sulfaphenazole/pharmacology

1137.0

Mixed Function Oxygenases/immunology

240.0

Steroid Hydroxylases/immunology

266.0

Cross-Over Studies

132.0

Drug Evaluation

41.0

Heterozygote

90.0

Homozygote

90.0

Hypoglycemic Agents/*pharmacokinetics

3100.0

Single-Blind Method

20.0

Insulin/blood

20.0

Population Surveillance

21.0

Time Factors

180.0

Blood Glucose/metabolism

30.0

Linkage Disequilibrium

20.0

Mixed Function Oxygenases/genetics

37.0

Tolbutamide/*pharmacokinetics

3100.0

DNA, Complementary/metabolism

50.0

Imidazoles/pharmacokinetics/*pharmacology

240.0

Isoenzymes/antagonists & inhibitors/genetics/metabolism

642.0

Adolescent

190.0

Gene Frequency/genetics

61.0

Polymorphism, Restriction Fragment Length

30.0

Turkey

32.0

International Normalized Ratio

827.0

Cytochrome P-450 Enzyme System/*genetics/physiology

228.0

Diclofenac/*metabolism/pharmacokinetics

2100.0

Microsomes, Liver/metabolism

158.0

Steroid Hydroxylases/*genetics/physiology

266.0

Administration, Oral

141.0

Cytochrome P-450 Enzyme System/*genetics/*metabolism

1020.0

Imidazoles/*pharmacokinetics

321.0

Spain

20.0

Steroid Hydroxylases/*genetics/*metabolism

571.0

Sweden

20.0

Tetrazoles/*pharmacokinetics

2100.0

Chromatography, High Pressure Liquid/*methods

43.0

Cytochrome P-450 Enzyme System/genetics/metabolism

511.0

Reference Values

100.0

Sensitivity and Specificity

60.0

Spectrum Analysis, Mass/*methods

37.0

Steroid Hydroxylases/genetics/metabolism

218.0

Models, Chemical

71.0

Oxidoreductases, N-Demethylating/*metabolism

56.0

Cytochrome P-450 CYP1A2/*metabolism

33.0

Pharmaceutical Preparations/*metabolism

1213.0

Coumarins/metabolism

416.0

Cytochrome P-450 CYP2D6

45.0

Cytochrome P-450 Enzyme System/*genetics/metabolism

1311.0

NADP/metabolism

54.0

NADPH-Ferrihemoprotein Reductase/*genetics/metabolism

240.0

Salmonella typhimurium/*genetics

342.0

Steroid Hydroxylases/genetics

311.0

Enzyme Inhibitors/metabolism/*pharmacology

317.0

Microsomes, Liver/drug effects/*enzymology/metabolism

222.0

Rats, Wistar

50.0

DNA Adducts/*metabolism

24.0

Microsomes, Liver/*drug effects/metabolism

430.0

Rabbits

130.0

Cytochrome P-450 Enzyme System/physiology

27.0

Double-Blind Method

60.0

Aged

600.0

Cytochrome P-450 Enzyme System/*biosynthesis/genetics

57.0

Enzyme Induction

91.0

Reverse Transcriptase Polymerase Chain Reaction

110.0

Rifampin/*pharmacology

48.0

Aryl Hydrocarbon Hydroxylases/metabolism

510.0

Cytochrome P-450 CYP1A2/metabolism

88.0

Sex Factors

30.0

Cytochrome P-450 Enzyme System/*physiology

915.0

Hydroxylation/drug effects

822.0

Microsomes, Liver/*drug effects/enzymology

1029.0

Mixed Function Oxygenases/antagonists & inhibitors/metabolism

736.0

Steroid Hydroxylases/antagonists & inhibitors/metabolism

444.0

Anticoagulants/*administration & dosage

37.0

Cohort Studies

40.0

Warfarin/*administration & dosage

333.0

Predictive Value of Tests

40.0

DNA, Complementary/biosynthesis

23.0

Haloperidol/*pharmacokinetics

2100.0

Microsomes, Liver/enzymology/*metabolism

1012.0

Gene Frequency

70.0

Aged, 80 and over

200.0

*Gene Expression Regulation, Enzymologic

61.0

Hepatocytes/enzymology

426.0

RNA, Messenger/analysis

30.0

Receptors, Cytoplasmic and Nuclear/*physiology

23.0

Transcription Factors/*physiology

20.0

Transcription, Genetic

50.0

African Continental Ancestry Group

31.0

*Genetics, Population

30.0

*Cytochrome P-450 Enzyme System/genetics/metabolism/physiology

266.0

Mephenytoin/metabolism

318.0

Omeprazole/metabolism

337.0

Phenytoin/metabolism

250.0

Isoenzymes/genetics/metabolism

85.0

Research Support, U.S. Gov't, Non-P.H.S.

60.0

Saccharomyces cerevisiae/enzymology

35.0

Antilipemic Agents/*pharmacology

25.0

Cytochrome P-450 CYP1A2/antagonists & inhibitors/metabolism

430.0

Cytochrome P-450 CYP2D6/metabolism

1025.0

Cytochrome P-450 CYP2E1/metabolism

716.0

Mixed Function Oxygenases/metabolism

139.0

Electron Transport Complex IV/*metabolism

211.0

Plant Proteins/*metabolism

220.0

Genetic Engineering

22.0

Mutagenicity Tests

31.0

NADPH-Ferrihemoprotein Reductase/genetics/metabolism

342.0

Enzyme Induction/drug effects

123.0

Oxidoreductases, N-Demethylating/biosynthesis

225.0

RNA, Messenger/biosynthesis/drug effects

23.0

Rifampin/pharmacology

46.0

Liver/drug effects/*enzymology

25.0

Microsomes/metabolism

75.0

Molecular Sequence Data

180.0

Sequence Alignment

50.0

Sequence Analysis, DNA

40.0

Sequence Homology, Nucleic Acid

30.0

Cytochrome P-450 Enzyme System/*biosynthesis/genetics/metabolism

213.0

RNA, Messenger/biosynthesis

50.0

*Pharmacogenetics

612.0

Macaca fascicularis

31.0

Insects

42.0

Phenobarbital/pharmacology

58.0

Cytochrome P-450 CYP1A2/antagonists & inhibitors

213.0

Cytochrome P-450 CYP2D6/antagonists & inhibitors

342.0

Mixed Function Oxygenases/antagonists & inhibitors

517.0

Steroid Hydroxylases/antagonists & inhibitors

550.0

Cytochrome P-450 Enzyme System/*drug effects

430.0

Dapsone/*pharmacology

220.0

Drug Combinations

30.0

Pilot Projects

20.0

Aryl Hydrocarbon Hydroxylases/*metabolism

1020.0

Cattle

30.0

Hypoglycemic Agents/pharmacokinetics

375.0

Protein Binding

140.0

Tolbutamide/pharmacokinetics

3100.0

Cytochrome P-450 Enzyme System/*chemistry/*metabolism

635.0

Liver/metabolism

40.0

Microsomes, Liver/enzymology/metabolism

913.0

Binding, Competitive

30.0

Chlorzoxazone/metabolism

210.0

Cytochrome P-450 Enzyme System/metabolism

124.0

Hydrogen-Ion Concentration

20.0

Phenacetin/metabolism

218.0

Steroid Hydroxylases/metabolism

1117.0

Steroid Hydroxylases/*genetics/metabolism

1047.0

Electrophoresis, Agar Gel

20.0

Polymerase Chain Reaction

110.0

Antihypertensive Agents/*pharmacokinetics

233.0

Diclofenac/pharmacokinetics

375.0

Losartan/*pharmacokinetics

2100.0

Receptors, Angiotensin/*antagonists & inhibitors

22.0

Anti-Bacterial Agents/*pharmacology

43.0

Antibiotics, Antitubercular/*pharmacology

214.0

Isoenzymes/antagonists & inhibitors/genetics/*metabolism

321.0

RNA, Messenger/genetics/metabolism

20.0

Chi-Square Distribution

40.0

Confidence Intervals

20.0

Mutation/*genetics

20.0

Anticonvulsants/*pharmacokinetics

220.0

Enzyme Inhibitors/pharmacokinetics

266.0

Omeprazole/pharmacokinetics

2100.0

Phenytoin/*pharmacokinetics

2100.0

Catalysis/drug effects

210.0

Methylation

122.0

Microsomes, Liver/*enzymology/metabolism

517.0

Enzyme Inhibitors/pharmacokinetics/*pharmacology

218.0

Cyclooxygenase Inhibitors/*pharmacokinetics

3100.0

DNA, Complementary

70.0

Cytochrome P-450 Enzyme System/*biosynthesis

44.0

Rats, Sprague-Dawley

110.0

Mephenytoin/*metabolism

222.0

Mutagenesis, Site-Directed

70.0

Peptide Fragments/genetics/metabolism

21.0

Steroid Hydroxylases/genetics/*metabolism

428.0

Substrate Specificity/genetics

24.0

Australia

21.0

*Health Policy

25.0

Cytochrome P-450 Enzyme System/drug effects/*physiology

266.0

Fluvoxamine/*pharmacology

312.0

Serotonin Uptake Inhibitors/*pharmacology

413.0

Isoenzymes/genetics/*metabolism

22.0

Phosphodiesterase Inhibitors/*metabolism

266.0

Anti-Inflammatory Agents, Non-Steroidal/*pharmacokinetics

240.0

Diclofenac/*pharmacokinetics

266.0

DNA, Complementary/genetics

50.0

Isoenzymes/*metabolism

124.0

Magnetic Resonance Spectroscopy

20.0

Microsomes, Liver/drug effects/*metabolism

25.0

Spectrum Analysis, Mass

91.0

Statistics

30.0

Anticonvulsants/*metabolism

337.0

Child, Preschool

50.0

Phenytoin/*metabolism

375.0

Brain/*enzymology

21.0

*Pharmacokinetics

36.0

Infusions, Intravenous

20.0

Enzyme Activation/drug effects

40.0

Electrophoresis, Polyacrylamide Gel

30.0

Arylamine N-Acetyltransferase/genetics

23.0

Cytochrome P-450 Enzyme System/genetics

54.0

Glutathione Transferase/genetics

20.0

Metabolic Detoxication, Drug

44.0

Odds Ratio

30.0

Dexamethasone/pharmacology

20.0

Hepatocytes/*enzymology/metabolism

240.0

Immunoblotting

40.0

Liver/enzymology/metabolism

26.0

Receptors, Cytoplasmic and Nuclear/metabolism

32.0

Receptors, Glucocorticoid/metabolism

23.0

Receptors, Steroid/metabolism

37.0

Binding Sites

190.0

Mixed Function Oxygenases/*antagonists & inhibitors/metabolism

26.0

Molecular Structure

70.0

Terpenes/pharmacology

27.0

Biotransformation/drug effects

26.0

Catalysis

162.0

Aryl Hydrocarbon Hydroxylases/*genetics/metabolism

1441.0

Biological Availability

31.0

Computer Simulation

20.0

Drug Design

30.0

Enzyme Activation

20.0

*Models, Molecular

54.0

Polymorphism, Single Nucleotide/*genetics

31.0

Tolbutamide/*metabolism

4100.0

Acetonitriles/pharmacology

250.0

Dimethyl Sulfoxide/pharmacology

33.0

Ethanol/pharmacology

23.0

Glucuronosyltransferase/*metabolism

35.0

Hepatocytes/*drug effects/*enzymology

342.0

Methanol/pharmacology

218.0

Solvents/*pharmacology

220.0

Ketoconazole/pharmacology

77.0

Mixed Function Oxygenases/antagonists & inhibitors/genetics/*metabolism

333.0

Omeprazole/pharmacology

325.0

Quinidine/pharmacology

36.0

Algorithms

51.0

Mixed Function Oxygenases/*antagonists & inhibitors

37.0

Spectrophotometry, Ultraviolet

63.0

Microsomes, Liver/drug effects/enzymology/*metabolism

211.0

Reproducibility of Results

80.0

Spectrometry, Fluorescence

30.0

Anti-HIV Agents/*pharmacology

21.0

Drug Evaluation, Preclinical

31.0

Drug Evaluation, Preclinical/*methods

412.0

DNA/genetics

20.0

Japan

130.0

Methyltransferases/genetics

211.0

Polymorphism, Genetic/genetics

71.0

Clinical Trials

30.0

Recombinant Proteins/antagonists & inhibitors/genetics/metabolism

413.0

Anti-Infective Agents/*pharmacokinetics

266.0

Microsomes/enzymology

65.0

*Oxazolidinones

250.0

Cytochrome P-450 CYP2D6/*genetics

46.0

Drug Administration Schedule

40.0

Benzimidazoles/pharmacology

24.0

Liver/drug effects/enzymology

46.0

Crystallography, X-Ray

30.0

Heme/chemistry

29.0

Hydrogen Bonding

21.0

Ligands

40.0

Progesterone/*metabolism

25.0

Protein Conformation

80.0

Protein Structure, Secondary

30.0

Protein Structure, Tertiary

20.0

Point Mutation

40.0

Interleukin-6/*metabolism

21.0

Liver/enzymology

61.0

Isoenzymes

42.0

Silymarin/*pharmacology

211.0

Tretinoin/*metabolism

24.0

beta-Naphthoflavone/pharmacology

26.0

Antidepressive Agents/*pharmacology

27.0

Bicyclo Compounds

233.0

*Hypericum

222.0

Phloroglucinol/analogs & derivatives

233.0

*Plants, Medicinal

34.0

Citrus/*metabolism

240.0

Coumarins/pharmacology

210.0

Cytochrome P-450 Enzyme System/*antagonists & inhibitors/*metabolism

27.0

Enzyme-Linked Immunosorbent Assay

40.0

Microsomes/*enzymology

36.0

Pharmaceutical Preparations/metabolism

721.0

Anti-Inflammatory Agents, Non-Steroidal/blood/*pharmacokinetics

2100.0

Liver/drug effects/enzymology/metabolism

216.0

Molecular Probes/metabolism

266.0

Pharmacogenetics/*methods

211.0

*Phenotype

31.0

Biotransformation/*genetics

233.0

Antibodies, Blocking/pharmacology

55.0

Cyclooxygenase Inhibitors/*metabolism

266.0

Cytochrome P-450 Enzyme System/biosynthesis/genetics/*metabolism

318.0

Steroid Hydroxylases/biosynthesis/genetics/*metabolism

266.0

Amino Acid Sequence

130.0

Amino Acid Substitution

60.0

Diclofenac/metabolism

1071.0

Recombinant Proteins/chemistry/metabolism

20.0

Sequence Homology, Amino Acid

40.0

Microsomes, Liver/*drug effects/*enzymology

240.0

Steroid Hydroxylases/antagonists & inhibitors/*metabolism

444.0

Linoleic Acid/*metabolism

250.0

Cross Reactions

30.0

Cytochrome P-450 Enzyme System/immunology/*metabolism

426.0

Mixed Function Oxygenases/immunology/*metabolism

233.0

Gene Expression Regulation, Neoplastic

30.0

Liver Neoplasms

20.0

RNA, Messenger/genetics

20.0

Reverse Transcriptase Polymerase Chain Reaction/methods

20.0

Steroid Hydroxylases/drug effects

266.0

Blood Pressure/drug effects

30.0

Fatty Acids, Unsaturated/pharmacology

23.0

Immunohistochemistry

30.0

Oxidoreductases, N-Demethylating/metabolism

35.0

Isoenzymes/*antagonists & inhibitors

618.0

Microsomes

214.0

Cytochrome P-450 CYP2E1/antagonists & inhibitors/metabolism

240.0

Diclofenac/*pharmacology

375.0

Disulfiram/*pharmacology

228.0

Erythromycin/*pharmacology

314.0

Phenytoin/chemistry

2100.0

Progesterone/chemistry

2100.0

Cytochrome P-450 Enzyme System/*chemistry/metabolism

325.0

Steroid Hydroxylases/*chemistry/metabolism

360.0

DNA, Complementary/*biosynthesis

433.0

*Ginsenosides

222.0

Panax/*chemistry

218.0

Plant Extracts/*pharmacology

45.0

Saponins/*pharmacology

220.0

Cloning, Molecular

40.0

DNA/blood

31.0

Fluorescent Dyes

20.0

*Point Mutation

20.0

Polymerase Chain Reaction/methods

20.0

Dogs

50.0

Haplorhini

20.0

Testosterone/metabolism

32.0

Serotonin Uptake Inhibitors/metabolism

266.0

Age Factors

50.0

Liver/*metabolism

30.0

Steroid Hydroxylases/chemistry

250.0

Xenobiotics/*metabolism

35.0

Anticoagulants/*metabolism

26.0

Warfarin/*metabolism

240.0

Benzodiazepines

29.0

Frozen Sections

22.0

B-Lymphocytes/enzymology

25.0

Serotonin Uptake Inhibitors/*pharmacokinetics

240.0

*Drug Interactions

521.0

Anticoagulants/*administration & dosage/therapeutic use

233.0

Vitamin K/administration & dosage

2100.0

Warfarin/*administration & dosage/therapeutic use

266.0

Gene Expression Regulation, Enzymologic

50.0

Cytochrome P-450 CYP2D6/antagonists & inhibitors/metabolism

350.0

Fluvoxamine/pharmacology

214.0

Asian Continental Ancestry Group/*genetics

82.0

Benzoflavones/pharmacology

48.0

Case-Control Studies

50.0

Hemorrhage/chemically induced/*genetics

2100.0

Electrochemistry

22.0

Mutation/genetics

20.0

Oligonucleotide Array Sequence Analysis/*methods

21.0

B-Lymphocytes/metabolism

21.0

Microsomes/drug effects/enzymology/metabolism

250.0

Cytochrome P-450 Enzyme System/antagonists & inhibitors/metabolism

411.0

*Alleles

40.0

*Mutation

30.0

Isomerism

31.0

Oxygen/metabolism

20.0

Steroid Hydroxylases/antagonists & inhibitors/genetics/*metabolism

375.0

Child

110.0

Dealkylation

610.0

Warfarin/chemistry/*pharmacokinetics

3100.0

Absorption

21.0

Cystic Fibrosis/*metabolism

24.0

Tissue Distribution

30.0

Cell Differentiation

20.0

*Gene Expression Regulation, Neoplastic

20.0

Alkylation

22.0

Cytochrome P-450 Enzyme System/chemistry/genetics/*metabolism

225.0

Anti-Inflammatory Agents, Non-Steroidal/metabolism

450.0

Sulfonamides/metabolism

228.0

Warfarin/metabolism

746.0

HIV Protease Inhibitors/*pharmacology

27.0

Terpenes/*pharmacology

315.0

Aryl Hydrocarbon Hydroxylases/genetics

312.0

Enzyme Inhibitors/metabolism

20.0

Risk Assessment

20.0

Blood Loss, Surgical/statistics & numerical data

520.0

Blood Transfusion/utilization

520.0

Cost-Benefit Analysis

54.0

Hospital Costs/statistics & numerical data

520.0

Length of Stay/statistics & numerical data

514.0

Osteoarthritis, Knee/epidemiology/*surgery

521.0

*Outcome Assessment (Health Care)

511.0

Perioperative Care

520.0

Postoperative Complications/epidemiology

510.0

Turkey/epidemiology

56.0

Cytochrome P-450 CYP2E1/*antagonists & inhibitors/metabolism

225.0

Linear Models

20.0

Cytochrome P-450 Enzyme System/*chemistry/*genetics/metabolism

266.0

Anti-Arrhythmia Agents/*pharmacokinetics

233.0

Imidazoles/blood/*pharmacokinetics

2100.0

Cell Line, Tumor

40.0

Genetic Vectors

30.0

Promoter Regions (Genetics)

30.0

Glucuronosyltransferase/metabolism

27.0

Mutagens/*metabolism

25.0

Steroid Hydroxylases/immunology/*metabolism

2100.0

Steroid Hydroxylases/*physiology

233.0

Saccharomyces cerevisiae/genetics

20.0

Orphenadrine/pharmacology

250.0

Troleandomycin/pharmacology

35.0

Sertraline

330.0

Goats/*metabolism

240.0

Ditiocarb/pharmacology

211.0

Enzyme Induction/drug effects/physiology

213.0

Variation (Genetics)/genetics

21.0

Cyclophosphamide/*metabolism

233.0

Ifosfamide/*metabolism

250.0

Antibody Specificity

40.0

Serotonin Uptake Inhibitors/pharmacokinetics/*pharmacology

2100.0

DNA/analysis

40.0

Triazoles/*pharmacology

215.0

Mixed Function Oxygenases/*genetics/metabolism

24.0

Cytochrome P-450 CYP2D6/*metabolism

38.0

Baculoviridae/genetics

21.0

Biological Markers

30.0

Anti-Infective Agents/adverse effects/*metabolism

2100.0

*Variation (Genetics)

20.0

Treatment Outcome

30.0

Models, Statistical

21.0

*Promoter Regions (Genetics)

20.0

Antipsychotic Agents/chemistry/*metabolism

2100.0

Chromatography, High Pressure Liquid/methods

42.0

Phenothiazines/chemistry/*metabolism

2100.0

Aspergillosis/*drug therapy

266.0

Gene Expression/drug effects/genetics

214.0

Recombinant Proteins/chemistry/genetics/metabolism

20.0

Models, Biological

20.0

Statistics, Nonparametric

30.0

Metabolic Clearance Rate/drug effects/physiology

325.0

Sequence Analysis, DNA/methods

22.0

Spectrum Analysis, Mass/methods

25.0

Aspartic Acid/genetics/*metabolism

250.0

Cytochrome P-450 Enzyme System/antagonists & inhibitors/*chemistry

240.0

Naproxen/metabolism

240.0

Isoenzymes/immunology/*metabolism

233.0

Antitussive Agents/metabolism

250.0

Dextromethorphan/metabolism

327.0

Midazolam/metabolism

210.0

*Hydroxymethylglutaryl-CoA Reductase Inhibitors

210.0

Cytochrome P-450 CYP1A2

22.0

Cytochrome P-450 CYP2E1

21.0

Polymorphism, Genetic/drug effects/physiology

3100.0

Gene Frequency/drug effects/physiology

2100.0

Retrospective Studies

40.0

DNA Primers/genetics

20.0

Exons

30.0

Introns

20.0

NADP/pharmacology

29.0

DNA, Complementary/biosynthesis/genetics

36.0

Diuretics/*pharmacokinetics

2100.0

Sulfonamides/*pharmacokinetics

250.0

Aryl Hydrocarbon Hydroxylases/*biosynthesis

212.0

Anti-Inflammatory Agents, Non-Steroidal/*adverse effects

218.0

Amino Acids/chemistry

21.0

Polymorphism, Genetic/*physiology

22.0

Aryl Hydrocarbon Hydroxylases/biosynthesis

218.0

Fluorometry

22.0

Hepatocytes/*enzymology

320.0

Anti-Inflammatory Agents, Non-Steroidal/*metabolism

222.0

Quinolines/*pharmacokinetics

220.0

Anticoagulants/*pharmacology

22.0

Cyclooxygenase Inhibitors/pharmacology

34.0

Blood Proteins/metabolism

20.0

Aryl Hydrocarbon Hydroxylases/*biosynthesis/genetics

212.0

Gene Expression Regulation, Enzymologic/*drug effects

21.0

Oxidoreductases, N-Demethylating/genetics/metabolism

211.0

Isoenzymes/genetics

20.0

Diclofenac/*urine

2100.0

Polymerase Chain Reaction/*methods

20.0

Intestines/*enzymology

25.0

HL-60 Cells

20.0

Transcription Factors/metabolism

20.0

Randomized Controlled Trials

20.0

*Thiazolidinediones

22.0

Herb-Drug Interactions

225.0

Hemorrhage/chemically induced

212.0

Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors/metabolism

228.0

Drug Evaluation, Preclinical/methods

26.0

RNA, Messenger/biosynthesis/genetics

20.0

Aryl Hydrocarbon Hydroxylases/*chemistry/*metabolism

250.0

Flurbiprofen/metabolism

2100.0

Losartan/*pharmacokinetics/urine

2100.0

Substrate Specificity/physiology

29.0